• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

美布芬和伊他诺酮及其类似物在大鼠体内的代谢和药代动力学比较。

Comparison of the metabolism and pharmacokinetics of metbufen and itanoxone and their analogues in rats.

作者信息

Chanal J L, Audran M, Bret M C, Cousse H, Fauran F, Rieu J P

机构信息

Physical Laboratory, Faculté de Pharmacie, Montpellier, France.

出版信息

Arzneimittelforschung. 1988 Oct;38(10):1454-60.

PMID:3196384
Abstract

Metbufen, II, itanoxone, I, and two other derivatives of gamma-aryl-gamma-keto-substituted butyric acids labelled with 14C in their carbonyl group were synthesized for a metabolic investigation in rats. Profound changes in pharmacokinetic parameters, most specifically in the distribution, elimination, and metabolic pathways, were induced by substitution in the aromatic nucleus or changes in saturation of the aliphatic chain. The metabolites isolated from plasma and urine were identified by gas chromatography and mass spectrometry, by comparison with chemical controls, revealing the processes of metabolism of these structural analogues. This difference in metabolism further understanding of the diversity of biological effects inherent in these compounds.

摘要

合成了美布洛芬(Metbufen)II、伊他诺酮(itanoxone)I以及另外两种羰基标记有¹⁴C的γ-芳基-γ-酮取代丁酸衍生物,用于在大鼠体内进行代谢研究。芳环上的取代或脂肪链饱和度的改变会引起药代动力学参数的显著变化,最明显的是分布、消除和代谢途径方面的变化。通过气相色谱和质谱,并与化学对照品比较,鉴定了从血浆和尿液中分离出的代谢产物,揭示了这些结构类似物的代谢过程。代谢方面的这种差异进一步加深了对这些化合物固有生物效应多样性的理解。

相似文献

1
Comparison of the metabolism and pharmacokinetics of metbufen and itanoxone and their analogues in rats.美布芬和伊他诺酮及其类似物在大鼠体内的代谢和药代动力学比较。
Arzneimittelforschung. 1988 Oct;38(10):1454-60.
2
Absorption, distribution, metabolism and excretion of [14C]ebastine after a single administration in rats.大鼠单次给药后[14C]依巴斯汀的吸收、分布、代谢和排泄
Arzneimittelforschung. 1994 Apr;44(4):527-38.
3
Pharmacokinetics of the new antihypertensive agent nipradilol in rats. 1st communication: Metabolism and disposition after single oral administration of [14C]nipradilol.新型抗高血压药物尼普地洛在大鼠体内的药代动力学。首次通讯:单次口服[14C]尼普地洛后的代谢与处置
Arzneimittelforschung. 1985;35(11):1674-9.
4
Pharmacokinetic properties of antileukemic and trypanocidal compounds with amidino and imidazolinyl groups.具有脒基和咪唑啉基的抗白血病及杀锥虫化合物的药代动力学性质。
Arzneimittelforschung. 1984;34(11):1542-51.
5
The metabolic disposition of (S)-2-(3-tert-butylamino-2-hydroxypropoxy)-3-cyanopyridine in rats, dogs, and humans.(S)-2-(3-叔丁基氨基-2-羟基丙氧基)-3-氰基吡啶在大鼠、狗和人体内的代谢情况。
Drug Metab Dispos. 1980 May-Jun;8(3):163-7.
6
Pharmacokinetics, metabolism and elimination of itanoxone in humans.伊他诺酮在人体内的药代动力学、代谢及消除
Eur J Drug Metab Pharmacokinet. 1983 Jul-Sep;8(3):287-96. doi: 10.1007/BF03188759.
7
Identification of urinary and biliary metabolites of alprenolol in the rat.大鼠体内阿普洛尔的尿液和胆汁代谢产物的鉴定
Xenobiotica. 1979 Feb;9(2):93-106. doi: 10.3109/00498257909038710.
8
Absorption, distribution, metabolism and excretion of [14C]ebastine after repeated oral administration in rats.大鼠重复口服给予[14C]依巴斯汀后的吸收、分布、代谢及排泄
Arzneimittelforschung. 1994 Apr;44(4):538-43.
9
Pharmacokinetics and metabolism of ryodipine in rats.大鼠中硝苯地平的药代动力学与代谢
Arzneimittelforschung. 1985;35(5):808-13.
10
Metabolism of ethyl 2-(4-chlorophenyl)-5-(2-furyl)-oxazole-4-acetate, a new hypolipidemic agent, in the rat, rabbit, and dog. Glucuronidation of carboxyl group and cleavage of furan ring.新型降血脂药2-(4-氯苯基)-5-(2-呋喃基)-恶唑-4-乙酸乙酯在大鼠、兔和犬体内的代谢。羧基的葡萄糖醛酸化及呋喃环的裂解。
Drug Metab Dispos. 1987 Mar-Apr;15(2):262-6.

引用本文的文献

1
Dissecting CYP1A2 Activation by Arylalkanoic Acid Prodrugs toward the Development of Anti-Inflammatory Agents.剖析芳烷酸前药对 CYP1A2 的激活作用,以开发抗炎药物。
Int J Mol Sci. 2023 Dec 28;25(1):435. doi: 10.3390/ijms25010435.